Evidence map›Paper›PMID 36510125›Full record

ArticleBMC bioinformatics2022

Boosting tissue-specific prediction of active cis-regulatory regions through deep learning and Bayesian optimization techniques.

Luca Cappelletti, Alessandro Petrini, Jessica Gliozzo, Elena Casiraghi, Max Schubach, Martin Kircher, Giorgio Valentini

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

Luca CappellettiAnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Milan, Italy.
Alessandro PetriniAnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Milan, Italy.
Jessica GliozzoAnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Milan, Italy.
Elena CasiraghiAnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Milan, Italy.
Max SchubachBerlin Institute of Health at Charité, Universitätsmedizin Berlin, Berlin, Germany.
Martin KircherBerlin Institute of Health at Charité, Universitätsmedizin Berlin, Berlin, Germany.
Giorgio ValentiniAnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Milan, Italy. valentini@di.unimi.it.ORCID http://orcid.org/0000-0002-5694-3919
University of Milan · ITBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DE

Funding

Università degli Studi di Milano PSR 2020 project "Machine Learning and Data Analytics for Genomic Medicine"
6 · The paper itself

Abstract

backgroundCis-regulatory regions (CRRs) are non-coding regions of the DNA that fine control the spatio-temporal pattern of transcription; they are involved in a wide range of pivotal processes such as the development of specific cell-lines/tissues and the dynamic cell response to physiological stimuli. Recent studies showed that genetic variants occurring in CRRs are strongly correlated with pathogenicity or deleteriousness. Considering the central role of CRRs in the regulation of physiological and pathological conditions, the correct identification of CRRs and of their tissue-specific activity status through Machine Learning methods plays a major role in dissecting the impact of genetic variants on human diseases. Unfortunately, the problem is still open, though some promising results have been already reported by (deep) machine-learning based methods that predict active promoters and enhancers in specific tissues or cell lines by encoding epigenetic or spectral features directly extracted from DNA sequences.

resultsWe present the experiments we performed to compare two Deep Neural Networks, a Feed-Forward Neural Network model working on epigenomic features, and a Convolutional Neural Network model working only on genomic sequence, targeted to the identification of enhancer- and promoter-activity in specific cell lines. While performing experiments to understand how the experimental setup influences the prediction performance of the methods, we particularly focused on (1) automatic model selection performed by Bayesian optimization and (2) exploring different data rebalancing setups for reducing negative unbalancing effects.

conclusionsResults show that (1) automatic model selection by Bayesian optimization improves the quality of the learner; (2) data rebalancing considerably impacts the prediction performance of the models; test set rebalancing may provide over-optimistic results, and should therefore be cautiously applied; (3) despite working on sequence data, convolutional models obtain performance close to those of feed forward models working on epigenomic information, which suggests that also sequence data carries informative content for CRR-activity prediction. We therefore suggest combining both models/data types in future works.

Indexed as

Deep LearningBayes TheoremHumansMachine LearningNeural Networks, ComputerRegulatory Sequences, Nucleic AcidBayesian optimizationDeep learningNeural networksPrediction of cis-regulatory region

Identifiers

PMID36510125
PMCPMC9743524
OpenAlexW4311134061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.